Page last updated: 2024-11-02

piracetam and Constriction, Pathological

piracetam has been researched along with Constriction, Pathological in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardid, D1
Lamberty, Y1
Alloui, A1
Coudore-Civiale, MA1
Klitgaard, H1
Eschalier, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Placebo-Controlled Crossover Trial of Levetiracetam on Ethanol Intake[NCT01168687]46 participants (Actual)Interventional2008-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Standard Alcoholic Drinks Per Treatment Period

The primary outcome of this study is to determine the effect of levetiracetam on alcohol consumption as measured by change in # of drinks during each treatment period. (NCT01168687)
Timeframe: During each 14 day treatment period

Interventionnumber of drinks per treatment period (Mean)
All Subjects (n = 46) Placebo41.2
All Subjects (n = 46) Levetiracetam45.4

Other Studies

1 other study available for piracetam and Constriction, Pathological

ArticleYear
Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.
    European journal of pharmacology, 2003, Jul-18, Volume: 473, Issue:1

    Topics: Acute Disease; Analgesics; Animals; Carbamazepine; Chronic Disease; Constriction, Pathologic; Diabet

2003